Pricing Log in Create free account

Bio-Techne Corp (TECH) vs Twist Bioscience Corporation (TWST)

Bio-Techne Corp and Twist Bioscience Corporation are both Biotechnology companies. Bio-Techne Corp is the larger, with a market value of $11.4B against $10.1B — 1.1× the size. Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; Bio-Techne Corp trades at 62.1×. Twist Bioscience Corporation grew revenue faster over the last twelve months: 19.2% against −0.38%. Bio-Techne Corp has the higher net margin (15.0% vs −31.7%) and the higher return on invested capital (7.70% vs −30.8%). Across the 19 metrics below, Bio-Techne Corp leads on 16 and Twist Bioscience Corporation on 3.

Valuation

Metric TECH TWST Biotechnology median
P/E 62.10 n/m 12.43
P/S 9.33 22.08 10.53
P/B 5.38 21.39 2.24
Price to free cash flow 43.05 n/m 22.59
EV/EBITDA 32.30 n/m 0.69
EV/Sales 9.28 21.73 9.92
Earnings yield 1.61% (1.45%) (34.94%)
Free cash flow yield 2.32% (1.00%) (23.17%)

Profitability

Metric TECH TWST Biotechnology median
Gross margin 65.77% 51.97% 68.94%
Operating margin 20.73% (33.58%) 0.00%
Net margin 14.97% (31.66%) 0.00%
Free cash flow margin 21.66% (22.15%) 0.00%
Return on equity 9.03% (29.59%) (54.09%)
Return on assets 7.07% (20.78%) (46.84%)
Return on invested capital 7.70% (30.83%) 0.00%

Growth

Metric TECH TWST Biotechnology median
Revenue growth (TTM) (0.38%) 19.19% 6.72%
EPS growth (last fiscal year) 152.17% 63.89% 29.36%
Revenue growth, 5-year CAGR 5.47% 33.11% 9.96%
Net income growth, 5-year CAGR 5.31% 0.00% 0.00%

Health

Metric TECH TWST Biotechnology median
Debt to equity 0.09 0.03 0.00
Current ratio 4.55 2.67 5.00
Net debt to EBITDA (0.19) 1.95 1.01

Dividend

Metric TECH TWST Biotechnology median
Dividend yield 0.44% — 0.40%
Payout ratio 0.28 — —

Size

Metric TECH TWST Biotechnology median
Market cap 11.41b 10.06b 177.44m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack